Aydin OC, Aydin S, Guney HZ. Defining the awareness and attitude of the clinicians through pharmacovigilance in Turkey. World J Clin Cases 2023; 11(20): 4865-4873 [PMID: 37583988 DOI: 10.12998/wjcc.v11.i20.4865]
Corresponding Author of This Article
Ozlem Celik Aydin, MD, Doctor, Department of Medical Pharmacology, Gazi University Faculty of Medicine, Besevler, Ankara 06500, Turkey. ozlemclk_89@hotmail.com
Research Domain of This Article
Pharmacology & Pharmacy
Article-Type of This Article
Prospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Jul 16, 2023; 11(20): 4865-4873 Published online Jul 16, 2023. doi: 10.12998/wjcc.v11.i20.4865
Table 1 Age distribution of the participants
Age range, yr
n (%)
18-25
19 (3)
26-35
388 (61.9)
36-44
103 (16.4)
45 and more
117 (18.7)
Total
627 (100)
Table 2 Specialty distribution of the participants
Specialization
n (%)
Emergency medicine
40 (6.4)
Family medicine
79 (12.6)
Anaesthesiology and resuscitation
49 (7.8)
Brain surgery
13 (2.1)
Paediatric surgery
3 (0.5)
Child psychiatry
7 (1.1)
Dermatology
6 (1)
Infectious diseases and clinical microbiology
11 (1.8)
Physical medicine and rehabilitation
29 (4.6)
General surgery
9 (1.4)
Thoracic surgery
20 (3.2)
Chest diseases
19 (3.2)
Eye diseases
15 (2.4)
Public health
5 (0.8)
Internal diseases
85 (13.6)
Gynaecology and obstetrics
22 (3.5)
Cardiology
16 (2.6)
Ear nose throat and diseases
5 (0.8)
Cardiovascular surgery
4 (0.6)
Neurology
19 (3)
Orthopaedics and traumatology
17 (2.7)
Pathology
5 (0.8)
Paediatrics
48 (7.7)
Psychiatry
43 (6.9)
Radiology
24 (3.8)
Medical genetics
18 (2.9)
Urology
16 (2.6)
Total
627 (100)
Table 3 Professional experience levels distribution of participants
Year of experience
n (%)
≤ 4
164 (26.2)
5–9
245 (39.1)
10–14
67 (10.7)
≥ 15
151 (24.1)
Total
627 (100)
Table 4 Ranking of participants’ reasons for not reporting adverse drug reactions
Reason
% (Ratio)
Difficulty in deciding whether ADRs have occurred
54 (320/592)
Insufficient time to report ADR
52 (312/592)
Consideration that the ADR is not significant enough to be reported
46 (275/592)
The absence of any reward for reporting
45 (270/592)
Believing that licensed drugs are safe
43 (255/592)
The notion that a single unreported ADR will not affect the database
41 (247/592)
Not knowing how to make a notification
34 (203/592)
Citation: Aydin OC, Aydin S, Guney HZ. Defining the awareness and attitude of the clinicians through pharmacovigilance in Turkey. World J Clin Cases 2023; 11(20): 4865-4873